• Je něco špatně v tomto záznamu ?

Progression from Subjective Cognitive Decline to Mild Cognitive Impairment or Dementia: The Role of Baseline Cognitive Performance

DJ. Jester, M. Vyhnálek, R. Andel, H. Marková, T. Nikolai, J. Laczó, V. Matusková, K. Cechová, K. Sheardova, J. Hort

. 2022 ; 86 (4) : 1763-1774. [pub] -

Jazyk angličtina Země Nizozemsko

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc22019538

BACKGROUND: Older adults with subjective cognitive decline (SCD) are at an increased risk of progression to mild cognitive impairment (MCI) or dementia. However, few have examined the specific cognitive tests that are associated with progression. OBJECTIVE: This study examined performance on 18 neuropsychological tests among participants with SCD who later progressed to MCI or dementia. METHODS: We included 131 participants from the Czech Brain Aging Study that had SCD at baseline. They completed a comprehensive neuropsychological battery including cognitive tests from the Uniform Data Set 2.0 enriched by the verbal memory test Rey Auditory Verbal Learning Test (RAVLT) and Rey-Osterrieth Complex Figure Test (ROCFT). RESULTS: Fifty-five participants progressed: 53% to non-amnestic MCI (naMCI), 44% to amnestic MCI (aMCI), and 4% to dementia. Scoring one SD below the mean at baseline on the RAVLT 1 and RAVLT 1-5 was associated with 133% (RAVLT 1; HR: 2.33 [1.50, 3.62]) and 122% (RAVLT 1-5; HR: 2.22 [1.55, 3.16]) greater risk of progression to MCI or dementia over 3.84 years on average. Worse performance on the RAVLT 5, RAVLT 1-5, RAVLT 30, and ROCFT-Recall was associated with progression to aMCI whereas worse performance on the RAVLT 1, TMT B, and Boston Naming Test was associated with progression to naMCI. CONCLUSION: At baseline, lower verbal memory performance was most strongly associated with progression to aMCI whereas lower executive or language performance was most strongly associated with progression to naMCI.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22019538
003      
CZ-PrNML
005      
20220804135742.0
007      
ta
008      
220720s2022 ne f 000 0|eng||
009      
AR
024    7_
$a 10.3233/JAD-215291 $2 doi
035    __
$a (PubMed)35253751
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Jester, Dylan J $u Department of Psychiatry, University of California San Diego, La Jolla, CA, USA $u Sam and Rose Stein Institute for Research on Aging, University of California San Diego, La Jolla, CA, USA
245    10
$a Progression from Subjective Cognitive Decline to Mild Cognitive Impairment or Dementia: The Role of Baseline Cognitive Performance / $c DJ. Jester, M. Vyhnálek, R. Andel, H. Marková, T. Nikolai, J. Laczó, V. Matusková, K. Cechová, K. Sheardova, J. Hort
520    9_
$a BACKGROUND: Older adults with subjective cognitive decline (SCD) are at an increased risk of progression to mild cognitive impairment (MCI) or dementia. However, few have examined the specific cognitive tests that are associated with progression. OBJECTIVE: This study examined performance on 18 neuropsychological tests among participants with SCD who later progressed to MCI or dementia. METHODS: We included 131 participants from the Czech Brain Aging Study that had SCD at baseline. They completed a comprehensive neuropsychological battery including cognitive tests from the Uniform Data Set 2.0 enriched by the verbal memory test Rey Auditory Verbal Learning Test (RAVLT) and Rey-Osterrieth Complex Figure Test (ROCFT). RESULTS: Fifty-five participants progressed: 53% to non-amnestic MCI (naMCI), 44% to amnestic MCI (aMCI), and 4% to dementia. Scoring one SD below the mean at baseline on the RAVLT 1 and RAVLT 1-5 was associated with 133% (RAVLT 1; HR: 2.33 [1.50, 3.62]) and 122% (RAVLT 1-5; HR: 2.22 [1.55, 3.16]) greater risk of progression to MCI or dementia over 3.84 years on average. Worse performance on the RAVLT 5, RAVLT 1-5, RAVLT 30, and ROCFT-Recall was associated with progression to aMCI whereas worse performance on the RAVLT 1, TMT B, and Boston Naming Test was associated with progression to naMCI. CONCLUSION: At baseline, lower verbal memory performance was most strongly associated with progression to aMCI whereas lower executive or language performance was most strongly associated with progression to naMCI.
650    _2
$a senioři $7 D000368
650    _2
$a kognice $7 D003071
650    12
$a kognitivní dysfunkce $x diagnóza $x psychologie $7 D060825
650    12
$a demence $x diagnóza $7 D003704
650    _2
$a lidé $7 D006801
650    _2
$a testy paměti a učení $7 D000073219
650    _2
$a neuropsychologické testy $7 D009483
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Vyhnálek, Martin $u Memory Clinic, Department of Neurology, Second Faculty of Medicine and Motol University Hospital, Charles University, Prague, Czech Republic $u International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic
700    1_
$a Andel, Ross $u Memory Clinic, Department of Neurology, Second Faculty of Medicine and Motol University Hospital, Charles University, Prague, Czech Republic $u International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic $u School of Aging Studies, University of South Florida, Tampa, FL, USA
700    1_
$a Marková, Hana $u Memory Clinic, Department of Neurology, Second Faculty of Medicine and Motol University Hospital, Charles University, Prague, Czech Republic $u International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic
700    1_
$a Nikolai, Tomás $u Memory Clinic, Department of Neurology, Second Faculty of Medicine and Motol University Hospital, Charles University, Prague, Czech Republic $u International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic
700    1_
$a Laczó, Jan $u Memory Clinic, Department of Neurology, Second Faculty of Medicine and Motol University Hospital, Charles University, Prague, Czech Republic $u International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic
700    1_
$a Matusková, Veronika $u Memory Clinic, Department of Neurology, Second Faculty of Medicine and Motol University Hospital, Charles University, Prague, Czech Republic $u International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic
700    1_
$a Cechová, Katerina $u Memory Clinic, Department of Neurology, Second Faculty of Medicine and Motol University Hospital, Charles University, Prague, Czech Republic $u International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic
700    1_
$a Sheardova, Katerina $u Memory Clinic, Department of Neurology, Second Faculty of Medicine and Motol University Hospital, Charles University, Prague, Czech Republic $u First Department of Neurology, St. Anne's University Hospital and Faculty of Medicine, Masaryk University, Brno, Czech Republic
700    1_
$a Hort, Jakub $u Memory Clinic, Department of Neurology, Second Faculty of Medicine and Motol University Hospital, Charles University, Prague, Czech Republic $u International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic
773    0_
$w MED00006350 $t Journal of Alzheimer's disease : JAD $x 1875-8908 $g Roč. 86, č. 4 (2022), s. 1763-1774
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35253751 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220720 $b ABA008
991    __
$a 20220804135736 $b ABA008
999    __
$a ok $b bmc $g 1822940 $s 1170781
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 86 $c 4 $d 1763-1774 $e - $i 1875-8908 $m Journal of Alzheimer's disease $n J Alzheimers Dis $x MED00006350
LZP    __
$a Pubmed-20220720
Zpět

Najít záznam

Citační ukazatele

Možnosti archivace